Cargando…

The therapeutic human CD38 antibody daratumumab improves the anti-myeloma effect of newly emerging multi-drug therapies

Detalles Bibliográficos
Autores principales: van der Veer, M S, de Weers, M, van Kessel, B, Bakker, J M, Wittebol, S, Parren, P W H I, Lokhorst, H M, Mutis, T
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3255255/
https://www.ncbi.nlm.nih.gov/pubmed/22829073
http://dx.doi.org/10.1038/bcj.2011.42
_version_ 1782220969061908480
author van der Veer, M S
de Weers, M
van Kessel, B
Bakker, J M
Wittebol, S
Parren, P W H I
Lokhorst, H M
Mutis, T
author_facet van der Veer, M S
de Weers, M
van Kessel, B
Bakker, J M
Wittebol, S
Parren, P W H I
Lokhorst, H M
Mutis, T
author_sort van der Veer, M S
collection PubMed
description
format Online
Article
Text
id pubmed-3255255
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher Nature Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-32552552012-01-11 The therapeutic human CD38 antibody daratumumab improves the anti-myeloma effect of newly emerging multi-drug therapies van der Veer, M S de Weers, M van Kessel, B Bakker, J M Wittebol, S Parren, P W H I Lokhorst, H M Mutis, T Blood Cancer J Letter to the Editor Nature Publishing Group 2011-10 2011-10-28 /pmc/articles/PMC3255255/ /pubmed/22829073 http://dx.doi.org/10.1038/bcj.2011.42 Text en Copyright © 2011 Macmillan Publishers Limited http://creativecommons.org/licenses/by-nc-nd/3.0/ This work is licensed under the Creative Commons Attribution-NonCommercial-No Derivative Works 3.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/
spellingShingle Letter to the Editor
van der Veer, M S
de Weers, M
van Kessel, B
Bakker, J M
Wittebol, S
Parren, P W H I
Lokhorst, H M
Mutis, T
The therapeutic human CD38 antibody daratumumab improves the anti-myeloma effect of newly emerging multi-drug therapies
title The therapeutic human CD38 antibody daratumumab improves the anti-myeloma effect of newly emerging multi-drug therapies
title_full The therapeutic human CD38 antibody daratumumab improves the anti-myeloma effect of newly emerging multi-drug therapies
title_fullStr The therapeutic human CD38 antibody daratumumab improves the anti-myeloma effect of newly emerging multi-drug therapies
title_full_unstemmed The therapeutic human CD38 antibody daratumumab improves the anti-myeloma effect of newly emerging multi-drug therapies
title_short The therapeutic human CD38 antibody daratumumab improves the anti-myeloma effect of newly emerging multi-drug therapies
title_sort therapeutic human cd38 antibody daratumumab improves the anti-myeloma effect of newly emerging multi-drug therapies
topic Letter to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3255255/
https://www.ncbi.nlm.nih.gov/pubmed/22829073
http://dx.doi.org/10.1038/bcj.2011.42
work_keys_str_mv AT vanderveerms thetherapeutichumancd38antibodydaratumumabimprovestheantimyelomaeffectofnewlyemergingmultidrugtherapies
AT deweersm thetherapeutichumancd38antibodydaratumumabimprovestheantimyelomaeffectofnewlyemergingmultidrugtherapies
AT vankesselb thetherapeutichumancd38antibodydaratumumabimprovestheantimyelomaeffectofnewlyemergingmultidrugtherapies
AT bakkerjm thetherapeutichumancd38antibodydaratumumabimprovestheantimyelomaeffectofnewlyemergingmultidrugtherapies
AT wittebols thetherapeutichumancd38antibodydaratumumabimprovestheantimyelomaeffectofnewlyemergingmultidrugtherapies
AT parrenpwhi thetherapeutichumancd38antibodydaratumumabimprovestheantimyelomaeffectofnewlyemergingmultidrugtherapies
AT lokhorsthm thetherapeutichumancd38antibodydaratumumabimprovestheantimyelomaeffectofnewlyemergingmultidrugtherapies
AT mutist thetherapeutichumancd38antibodydaratumumabimprovestheantimyelomaeffectofnewlyemergingmultidrugtherapies
AT vanderveerms therapeutichumancd38antibodydaratumumabimprovestheantimyelomaeffectofnewlyemergingmultidrugtherapies
AT deweersm therapeutichumancd38antibodydaratumumabimprovestheantimyelomaeffectofnewlyemergingmultidrugtherapies
AT vankesselb therapeutichumancd38antibodydaratumumabimprovestheantimyelomaeffectofnewlyemergingmultidrugtherapies
AT bakkerjm therapeutichumancd38antibodydaratumumabimprovestheantimyelomaeffectofnewlyemergingmultidrugtherapies
AT wittebols therapeutichumancd38antibodydaratumumabimprovestheantimyelomaeffectofnewlyemergingmultidrugtherapies
AT parrenpwhi therapeutichumancd38antibodydaratumumabimprovestheantimyelomaeffectofnewlyemergingmultidrugtherapies
AT lokhorsthm therapeutichumancd38antibodydaratumumabimprovestheantimyelomaeffectofnewlyemergingmultidrugtherapies
AT mutist therapeutichumancd38antibodydaratumumabimprovestheantimyelomaeffectofnewlyemergingmultidrugtherapies